Author Login IJIRT Partner Network (IPN) Login

Comparative analysis of Indian pharmaceutical companies during Covid

  • Unique Paper ID: 158201
  • Volume: 9
  • Issue: 9
  • PageNo: 163-169
  • Abstract:
  • The coronavirus pandemic's effects on India have primarily disrupted economic activities and resulted in fatalities. Almost every industry has suffered as domestic demand and exports have dramatically decreased, with some notable outliers where strong growth has been seen. Analysis of the effects and potential remedies for several important industries is attempted. Since the Covid-19 pandemic began, the pharmaceutical business has grown, particularly in India, the world's top producer of generic medications. In the beginning of 2020, it had a market of $55 billion and was booming in India, supplying hydroxychloroquine to countries all over the world, including the US, UK, Canada, and the Middle East.
Download article email to a friend

Cite This Article

  • ISSN: 2349-6002
  • Volume: 9
  • Issue: 9
  • PageNo: 163-169

Comparative analysis of Indian pharmaceutical companies during Covid

Related Articles

22 Feb, 2023

A Study on Analysis of Non -Performing Assets and its Impact on Profitability

Read More
21 Feb, 2023

Empirical studies on Indian IPO’s Market performance

Read More
21 Feb, 2023

A STUDY ON THE RELATION BETWEEN THE INDIAN STOCK MARKET AND INDIAN ECONOMY

Read More
13 Jan, 2023

A Study of Indian customers’ impulsive buying behavior of cosmetics through cybershopping

Read More
Impact Factor
8.01 (Year 2024)
UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now

Latest Publication

Archive

View More

Recent Conferences

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024

Submit inquiry